Diabete e MMG: “Riorganizzare il sistema sanitario e dare accesso all’innovazione alla medicina territoriale
Solo così il medico di base riprenderà il ruolo centrale di cura”
Solo così il medico di base riprenderà il ruolo centrale di cura”
- Il Comitato indipendente di monitoraggio della sicurezza dei dati raccomanda all'unanimità di proseguire lo studio globale di fase II/III su opaganib somministrato per via orale nei casi di polmonite grave da COVID-19 sulla base della revisione dei dati di sicurezza non in cieco relativi ai primi 255 pazienti trattati
GALWAY, Ireland, April 12, 2021 /PRNewswire/ -- In response to growing business demand, Aran Biomedical Teoranta, a leading biomaterials contract manufacturer of proprietary medical devices, today announced the creation of 150 new jobs over 3 years. Additionally, the Company announced its plan to build a new, purpose-built facility in Spiddal, Galway. The investment is supported by the Irish Government, through Údarás na Gaeltachta.
BRESCIA, Italy, April 9, 2021 /PRNewswire/ --
Roma 9 aprile 2021. Si è tenuto nei giorni scorsi un incontro virtuale, fortemente voluto da Women for Oncology – Italy, che ha visto la partecipazione attiva di oltre 40 oncologhe, collegate da tutta Italia.
Ecco i modelli italiani per far fronte alla pandemia delle malattie croniche. Gli specialisti: «Gli applicativi gestionali devono semplificare il lavoro del medico di medicina generale abbattendo i carichi burocratici e semplificandogli il lavoro».
PRAGUE, April 9, 2021 /PRNewswire/ -- Zentiva and mAbxience announce their collaboration for the launch of the ALYMSYS® (bevacizumab) following its European Marketing Authorisation on March 26th. The EC approval is based on a comprehensive clinical and scientific package which demonstrated biosimilarity of ALYMSYS® to the originator reference product.
SHANGHAI, April 8, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr. Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr. Manuel Hidalgo, Chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, to its Scientific Advisory Board. Drs. Rowinsky and Hidalgo wil...
“Ritardo diagnostico, gestione clinica complessa e assenza di terapie curative, che fare?”
LogPoint announces innovative SIEM architecture to benefit education, healthcare and local government.
BESTHESDA, Maryland and CASTRES, France, April 8, 2021 /PRNewswire/ -- The US biopharmaceutical company ValenzaBio and the French pharmaceutical group Pierre Fabre announced today the signing of a license agreement of a preclinical insulin-like growth factor-1 receptor (IGF-1R) antagonist antibody, for the treatment of Thyroid Eye Disease (TED), an endocrine disease with unmet medical need. ValenzaBio received from Pierre Fabre the worldwide and exclusive rights to develop and commercialize, outs...
Distributors' Extensive Support and Technical Expertise will Meet Growing Global Demand for the MolecuLight i:X® Fluorescence Wound Imaging Device
WILLINGTON, England, April 8, 2021 /PRNewswire/ -- Bionical Emas, a global specialist Clinical Research Organization (CRO) has today announced the launch of a Managed Access Program for Jazz Pharmaceuticals' medicinal product JZP-458 for the treatment of patients with Acute Lymphoblastic Leukaemia (ALL) and Lymphoblastic Lymphoma (LBL) following hypersensitivity to E. Coli-derived asparaginases. The Managed Access Program provides a mechanism through which unsolicited physician requests, to fulfi...
SEATTLE, 7 aprile 2021 /PRNewswire/-- LumiThera, Inc., azienda di dispositivi medici in fase commerciale che fornisce il trattamento di fotobiomodulazione (PBM) per disturbi e malattie oculari, ha oggi annunciato di aver ottenuto dei risultati positivi in LIGHTSITE II, lo studio clinico multicentrico condotto su pazienti affetti da degenerazione maculare senile (DMLE) secca.
TORONTO, April 7, 2021 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to provide an operational update with regards to its supply of EU-GMP medical cannabis products to the UK. To help alleviate bottlenecks and stock outs, the Company has established an offshore inventory of dried flower, for the express purpose of serving UK...
Con la teragnostica è possibile selezionare i pazienti non risponder, definendo terapie successive e follow-up
SEATTLE, April 7, 2021 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and disease, today announced positive findings in its LIGHTSITE II, multi-center clinical trial in dry Age-Related Macular Degeneration (AMD) patients.
SEOUL, South Korea, April 6, 2021 /PRNewswire/ -- Cell Biotech (KRX 049960), a probiotics & microbiome company, has acquired a European patent (Registration No. EP3453718) for the anticancer protein P8 originated from Lactobacillus rhamnosus for the new colorectal cancer drug "PP-P8".
